Loading...

Intracellular Staining Permeabilization Wash Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Perm/Wash, Permeabilization Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
421002 100 mL 76€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Intracellular Staining Permeabilization Wash Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Intracellular Staining Permeabilization Wash Buffer is used to permeabilize cells following fixation with Intracellular Staining Fixation Buffer (Cat. No. 420801). It is supplied as a 10X solution and should be diluted in deionized water prior to use. Intracellular Staining Permeabilization Wash Buffer has been formulated to have minimal effects on cells, reduce non-specific staining and enhance the signal to noise ratio. It can be used for antibody dilutions and cell washing during intracellular staining.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
The Intracellular Staining Perm wash buffer solution should be stored between 2°C and 8°C. Do not freeze.
Application

ICC, ICFC - Quality tested
IHC - Reported in the literature, not verified in house
Recommended Usage

For use in permeabilization, dilute Intracellular Staining Permeabilization Wash Buffer (10X) to 1X in DI water. Resuspend fixed cells in diluted Intracellular Staining Permeabilization Wash Buffer and centrifuge at 350 xg for 5-10 minutes, and repeat the process twice. It is recommended that the reagent be titrated for optimal performance for each application. Please see "Intracellular Cytokine Staining Protocol" on BioLegend's website for more details.

Application Notes

The Intracellular Staining Permeabilization Wash Buffer (10X) may have crystallization or precipitation observed when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is heavy precipitation observed after dilution to 1X working solution, the buffer can be filtered to clarify the solution.

Application References
  1. Smeltz RB. 2007. J. Immunol. 178:4786.
  2. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  3. del Rio ML, et al. 2011. Transplantation. 92:1085. PubMed
  4. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  5. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  6. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  7. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  8. Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
Product Citations
  1. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  2. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  3. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  4. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  5. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  6. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  7. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  8. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  9. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  10. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  11. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  12. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  13. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  14. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  15. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  16. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  17. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  18. Chan L, et al. 2022. Cells. 12: . PubMed
  19. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  20. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  21. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  22. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  23. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  24. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  25. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  26. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  27. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  28. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  29. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  30. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  31. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  32. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  33. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  34. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  35. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  36. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  37. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  38. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  39. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  40. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  41. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  42. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  43. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  44. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  45. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  46. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  47. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  48. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  49. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  50. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  51. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  52. Kim S, et al. 2020. Development. 147:00:00. PubMed
  53. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  54. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  55. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  56. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  57. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  58. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  59. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  60. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  61. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  62. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  63. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  64. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  65. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  66. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  67. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  68. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  69. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  70. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  71. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  72. Stewart CA, et al. 2020. bioRxiv. . PubMed
  73. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  74. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  75. Poli V, et al. 2021. iScience. 24:103256. PubMed
  76. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  77. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  78. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  79. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  80. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  81. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  82. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  83. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  84. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  85. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  86. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  87. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  88. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  89. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  90. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  91. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  92. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  93. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  94. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  95. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  96. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  97. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  98. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  99. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  100. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  101. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  102. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  103. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  104. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  105. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  106. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  107. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  108. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  109. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  110. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  111. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  112. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  113. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  114. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  115. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  116. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  117. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  118. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  119. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  120. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  121. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  122. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  123. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  124. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  125. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  126. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  127. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  128. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  129. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  130. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  131. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  132. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  133. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  134. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  135. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  136. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  137. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  138. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  139. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  140. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  141. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  142. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  143. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  144. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  145. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  146. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  147. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  148. Kim S, et al. 2020. Development. . PubMed
  149. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  150. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  151. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  152. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  153. Ma K, et al. 2022. iScience. 25:104347. PubMed
  154. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  155. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  156. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  157. Lau H, et al. 2020. Islets. 41:12. PubMed
  158. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  159. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  160. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  161. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  162. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  163. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  164. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  165. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  166. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  167. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  168. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  169. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  170. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  171. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  172. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  173. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  174. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  175. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  176. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  177. Lee G, et al. 2021. Viruses. 13: . PubMed
  178. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  179. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  180. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  181. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  182. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  183. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  184. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  185. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  186. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  187. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  188. Su Y, et al. 2020. Cell. 1479:183. PubMed
  189. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  190. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  191. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  192. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  193. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  194. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  195. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  196. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  197. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  198. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  199. Wang X, et al. 2022. Elife. 11:. PubMed
  200. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  201. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  202. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  203. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  204. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  205. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  206. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  207. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  208. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  209. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 08/26/2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account